Overview
Biocloner Health develops 3D bioprinters and offers biomaterials. The company provides engineering services for tissue engineering, regenerative medicine and research.
- Monday–Sunday
- 9:00–17:00
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 90 days for 2021). 1 of 6 audited by a statutory auditor.
- 202506/09/2026
- 202407/08/2025
- 202303/07/2024
- 202209/07/2023
- 202113/10/2022
- 202014/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
BioCloner Health at BioJapan 2026 in Yokohama
From October 7–9, the BioCloner Health team took part in BioJapan 2026 at PACIFICO Yokohama, one of Japan’s key meeting points for the biotechnology and life sciences community.
BioCloner Health opens a subsidiary in the USA!
BioCloner Health at NanoTech Poland 2026
A new dimension of practical knowledge: BioCloner Health workshops
BioCloner Desktop Pro in a research project
New Scientific 3D Printer Implemented at PANS in Chełm
BioCloner Health implemented a new 3D printer Scientific system at PANS in Chełm to advance engineering education and research initiatives.
Industry
Offer
- 3D bioprinter
- 3D research printer
- Research and development services
- Engineering design
- Rapid prototyping
Website technology
- Online shop
- WooCommerce
- Website
- WordPress
- Analytics and marketing
- Google Analytics
Public procurement
1 tender recorded as contractor, with a total value of $15,445.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 20, 2025 | Supply of a multi-head 3D printer for research and experimental applications as part of the “Dydaktyczna inicjatywa doskonałości” initiative | $15,445$15,445 | Państwowa Akademia Nauk Stosowanych w Chełmie |
Authorized Representatives
Manner of representation
Each member of the management board has the right to represent the company independently.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Valegro Limited | 8,701 | $1,175,175.58 | 70.0056% |
Maciej Bartosz Tabiszewskiage 48 | 3,107 | $419,638.03 | 24.998% |
Others | 621 | $83,873.58 | 4.9964% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2001-07-25.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Dec 4, 2024 | Merger registered |
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Bioresearch Groupsp. z o.o. | $776,186.19 | bioresearch.pl | ||
| PolbionicaS.A. | $356,011.70 | polbionica.com | ||
| BiocamS.A. | $327,799.68 | biocam.ai | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| MultiqureS.A. | $284,781.52 | purebiologics.com | ||
| FcbiotechS.A. | $246,877.92 | fcbiotech.pl | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| Monipol Biotech Plsp. z o.o. | $191,735.74 | monipol-biotech.com | ||
| Bactremsp. z o.o. | $181,958.36 | bactrem.pl | ||
| AI Corelabsp. z o.o. | $106,857.00 | aicorelab.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-10-15 | Share capital increase (3,389,500.00 PLN → 6,214,500.00 PLN) | |
| 2024-09-04 | Address change (Ul. Nowy Świat 39/1, 00-029, Warszawa → Ul. Wspólna 62, 00-684, Warszawa) | |
| 2024-04-17 | Name change (45stages → Biocloner Health) | |
| 2019-12-05 | Share capital increase (1,972,500.00 PLN → 3,389,500.00 PLN) | |
| 2019-05-27 | Address change (Ul. Elektryczna 1/3/216, 15-080, Białystok → Ul. Nowy Świat 39/1, 00-029, Warszawa) |
FAQ
Last updated: 2026-09-08